[ad_1] After nearly seven years at Novartis and more than four years as a member of the ECN, Ms. Tschudin will pursue her next chapter of leadership outside of Novartis…
Tag: M.D
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
[ad_1] SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases,…
Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer | BioSpace
[ad_1] Dr. Kjems succeeds Stan Bukofzer, M.D., following his retirement; Dr. Bukofzer will continue to serve as Strategic Advisor to Company SAN DIEGO–(BUSINESS WIRE)– Ocelot Bio, Inc., a clinical-stage biopharmaceutical…
M.D. Sass is betting big on these out-of-favor stocks, expecting growth, recession or not
[ad_1] When Ari Sass moved into the portfolio manager role at hedge fund M.D. Sass four years ago, it was a long-expected transition at the company his father had built,…